Luminex Launches FDA-Cleared CYP2D6 PGx Test | GenomeWeb

By Turna Ray

Luminex this week launched its first pharmacogenetic test, the xTAG CYP2D6 kit, after gaining 510(k) clearance from the US Food and Drug Administration.

The company said that the xTAG CYP2D6 kit is the first assay in a line of CYP tests that it is developing. The test is available through Luminex Molecular Diagnostics and distribution partner Fisher HealthCare.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.